Agenus Inc (AGEN) stock
AGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.29−0.44 (-6.54%)
Close on Nov 16, 2026Market cap $283.18MP/E –Yield –
Agenus enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Agenus's enterprise value was $303.72M on Nov 10, 2026, against $173.61M a year earlier. Over the last 5 years it ranged from -$271.41M to $6.93B, with a median of $98.59M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 10, 2026 | $303.72M | +139.1% |
| 2025 | Dec 31, 2025 | $127.02M | +161.6% |
| 2024 | Dec 31, 2024 | $48.55M | – |
| 2023 | Jan 31, 2023 | -$182.62M | – |
| 2022 | Dec 30, 2022 | -$183.71M | – |
| 2021 | Dec 31, 2021 | -$240.58M | -103.5% |
| 2018 | Jan 31, 2018 | $6.93B | +10.6% |
| 2017 | Dec 29, 2017 | $6.27B | -12.4% |
| 2016 | Dec 30, 2016 | $7.16B | +10.0% |
| 2015 | Dec 31, 2015 | $6.51B | – |
See a number that looks wrong?